Press Release Archives

Press Release

Certara Acquires Applied Biomath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Combined organization establishes the life Sciences industry’s largest quantitative systems pharmacology (QSP) center of excellence…

CertaraDecember 13, 2023

Press Release

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex…

CertaraNovember 21, 2023

Press Release

Certara Reports Third Quarter 2023 Financial Results

Reiterates Full Year 2023 Financial Guidance PRINCETON, N.J.— November 8, 2023-- Certara, Inc. (Nasdaq: CERT), a…

CertaraNovember 8, 2023

Press Release

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraOctober 11, 2023

Press Release

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines. PRINCETON, NJ –…

CertaraSeptember 19, 2023

Press Release

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

PRINCETON, N.J.— July 13, 2023-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJuly 13, 2023

Press Release

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel…

CertaraMarch 7, 2023

Press Release

Certara Announces Transition Plan For Chief Financial Officer

PRINCETON, N.J. – March 1, 2023 – Certara, Inc. (Nasdaq: CERT), announced today that John…

CertaraMarch 1, 2023

Press Release

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1^st, 2023

PRINCETON, N.J.— February 1, 2023-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraFebruary 1, 2023

Press Release

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J.— January…

CertaraJanuary 4, 2023

Press Release

Certara Acquires Applied Biomath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Certara Reports Third Quarter 2023 Financial Results

Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference

Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types

Certara Announces Transition Plan For Chief Financial Officer

Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1^st, 2023

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

Newsletter sign up

Quick links

Solutions

Contact